Study on malignant tumour
Conditions
Interventions
Sponsors
Department of Microbiology, The Chinese University of Hong Kong
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Chinese people aged 18 or above, no upper age limit; 3. Having newly diagnosed malignant tumour; 4. A new case referred to the Oncology Centre for management.
Exclusion criteria
Exclusion criteria: 1. Patients who have previously received cancer therapy; 2. Patients who will receive concurrent radiotherapy; 3. Patients with conditions rendering them incapable to answer questionnaires or provide oral and stool samples; 4. Subjects who are unable to give consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in gut and oral microbial community profiles measured by 16s and metagenomics sequencing before and after cancer therapy.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation of gut and oral microbial community profiles measured by 16s and metagenomics sequencing with respect to tumour type and toxicity.; | — |
Countries
China
Contacts
Public ContactProf. Paul KS Chan
The Chinese University of Hong Kong
Outcome results
None listed